Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
DOI10.1098/RSTA.2006.1769zbMATH Open1152.92324OpenAlexW2104800402WikidataQ51943913 ScholiaQ51943913MaRDI QIDQ5301882FDOQ5301882
Authors: Athanasius F. M. Marée, Richard A. Kublik, Diane T. Finegood, Leah Edelstein-Keshet
Publication date: 20 January 2009
Published in: Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1098/rsta.2006.1769
Recommendations
- Quantifying macrophage defects in type 1 diabetes
- Fractional Model for Type 1 Diabetes
- Modeling dynamic changes in type 1 diabetes progression: quantifying \(\beta\)-cell variation after the appearance of islet-specific autoimmune responses
- The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation
- Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical mod\-el\-ing
Cited In (13)
- Modeling Cyclic Waves of Circulating T Cells in Autoimmune Diabetes
- Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical mod\-el\-ing
- Mathematical model for BCG-based treatment of type 1 diabetes
- A mathematical model of T1D acceleration and delay by viral infection
- Modeling the effect of high calorie diet on the interplay between adipose tissue, inflammation, and diabetes
- Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes
- Modeling immune complex-mediated autoimmune inflammation
- Continuum model of T-cell avidity: understanding autoreactive and regulatory T-cell responses in type 1 diabetes
- Quantifying macrophage defects in type 1 diabetes
- The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation
- Fractional Model for Type 1 Diabetes
- The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance
- Modelling the impact of NETosis during the initial stage of systemic lupus erythematosus
This page was built for publication: Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5301882)